Autophagy Reprogramming in Cancer
Journal of Cellular Physiology · 2025
DOI: 10.1002/jcp.70107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Annie D Fuller und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Autophagy, Neoplasms, Cellular Reprogramming. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
During malignancy, metabolic reprogramming is critical for cancer cells to survive and thrive in nutrient‐ and oxygen‐poor conditions. Autophagy is a catabolic process through which intracellular components are degraded to support cells upon exposure to stressful conditions. While autophagy is protective during early cancer initiation, tumor cells may initiate cell‐intrinsic and cell‐extrinsic autophagy to support their survival in later stages of cancer. As autophagy is present at low levels in most tissues under homeostasis and upregulated in malignancy, there has been great interest in targeting the autophagy pathway for cancer therapy. Here, we discuss the mechanisms through which autophagy and autophagy‐related proteins act to limit carcinogenesis. We then review pro‐tumor roles for autophagy in tumor cells as well as in components of the tumor microenvironment. Finally, we discuss autophagy‐targeted approaches for cancer therapy. This review article highlights autophagy as a key player in cell metabolism that is often leveraged to support cancer progression and as a potential therapeutic target in a variety of cancer types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Section of Gastroenterology, Temple University Hospital, Philadelphia, Pennsylvania, USA.
- Center for Substance Abuse Research (CSAR), Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
- Center for Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Cancer & Cellular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Cancer Institute
Zitieren
APA
Fuller, A. D., Bordner, T. H., Staub, A. J., Jackson, J. L., Shanas, N., Crespo, J. M., Nazario-Lugo, W. A., Rukhsar, M., Tufano, A., Worrell, C., Reichenbach, Z. W., & Whelan, K. A. (2025). Autophagy Reprogramming in Cancer. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70107
Vancouver
Fuller AD, Bordner TH, Staub AJ, Jackson JL, Shanas N, Crespo JM, et al. Autophagy Reprogramming in Cancer. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70107
BibTeX
@article{Fuller2025,
author = {Fuller, Annie D and Bordner, Travis H and Staub, Abigail J and Jackson, Jazmyne L and Shanas, No'ad and Crespo, John M and Nazario-Lugo, William A and Rukhsar, Mazen and Tufano, Alex and Worrell, Courtney and Reichenbach, Zachary Wilmer and Whelan, Kelly A},
title = {Autophagy Reprogramming in Cancer},
journal = {Journal of Cellular Physiology},
year = {2025},
doi = {10.1002/jcp.70107}
}
EUVIMED